David Otiashvili

Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior—Outcomes of a randomized trial

David Otiashvili, Gvantsa Piralishvili, Z. Sikharulidze et al. · Drug and Alcohol Dependence · 2013 · 66 citations · Full text

Illicit Buprenorphine, Opioid Epidemic, Substance Abuse +14

Access to treatment for substance-using women in the Republic of Georgia: Socio-cultural and structural barriers

David Otiashvili, Irma Kirtadze, Kevin E. O’Grady et al. · International Journal of Drug Policy · 2013 · 60 citations · Full text

Substance Abuse, Substance Use, Substance-using Women +13

The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study

David Otiashvili, Tamar Mgebrishvili, Ada Beselia et al. · Harm Reduction Journal · 2022 · 51 citations · Full text

Twice Stigmatized: Provider's Perspectives on Drug-Using Women in the Republic of Georgia

Irma Kirtadze, David Otiashvili, Kevin E. O’Grady et al. · Journal of Psychoactive Drugs · 2013 · 38 citations

Interim effect evaluation of the hepatitis C elimination programme in Georgia: a modelling study

Josephine G. Walker, Tinatin Kuchuloria, David Sergeenko et al. · The Lancet Global Health · 2019 · 27 citations · Full text